Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Summary

Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

Atherectomy is a minimally invasive procedure that removes plaque from vessels. Atherectomy is especially valuable in eliminating highly calcified plaque. Atherectomy procedure may be used for coronary and peripheral vessels to open a blockage and restore blood flow. The atherectomy may be combined with angioplasty and stenting.

Coronary Artery Disease (CAD) refers to narrowing of the coronary arteries due to inadequate supply of blood and oxygen to cardiac muscles. Peripheral artery disease (PAD) is characterized by the build-up of atherosclerotic plaque in the lower extremities, which disturbs normal blood flow and can cause nerve and tissue damage. The high prevalence of these disease in the developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally-invasive techniques, such as angioplasty, stenting, and atherectomy. These procedures have replaced invasive artery bypass surgery as the first line of treatment for patients with PAD.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Atherectomy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Atherectomy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Atherectomy Devices market.
• Competitive dynamics insights and trends provided for Atherectomy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Cardiovascular Systems Inc, Boston Scientific Corp, Koninklijke Philips NV, Medtronic Plc, Avinger Inc, Becton Dickinson and Co, Angiodynamics Inc.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Atherectomy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Atherectomy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Atherectomy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Atherectomy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Please note: this is delivered as an Excel file.